These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10323665)

  • 1. Glibenclamide-induced hypoglycemic coma in 51 older patients with type 2 diabetes mellitus.
    Ben-Ami H; Nagachandran P; Mendelson A; Edoute Y
    J Am Geriatr Soc; 1999 May; 47(5):631-3. PubMed ID: 10323665
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risks of severe hypoglycemia after glibenclamide (daonil or euglucan). A report of 10 cases of coma observed during a period of 6 months].
    Raymond JP; Chimènes H; Klotz HP
    Diabete; 1971; 19(1):31-2. PubMed ID: 4999031
    [No Abstract]   [Full Text] [Related]  

  • 3. [On 4 cases of severe hypoglycemia (one of which with fatal evolution) after treatment with glibenclamide].
    Codaccioni JL; Rubin P; Mattei A; Vague P
    Diabete; 1971; 19(1):37-41. PubMed ID: 4999032
    [No Abstract]   [Full Text] [Related]  

  • 4. [Coma in type 2 diabete mellitus on metformin treatment].
    Renard C; Tellal S; Fevre G; Ragot C; Vest P; Foissaud V; Renaudeau C
    Ann Biol Clin (Paris); 2003; 61(1):84-7. PubMed ID: 12604391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypoglycemic accidents during treatment with antidiabetic sulfamides. Apropos of 5 cases of hypoglycemic coma in aged subjects].
    Brogard JM; Kuntzmann F; Touitou D; Dorner M
    Sem Hop; 1973 Sep; 49(37):2461-6. PubMed ID: 4359498
    [No Abstract]   [Full Text] [Related]  

  • 6. Glibenclamide and liver disease.
    Petrogiannopoulos C; Zacharof A
    Diabetes Care; 1997 Jul; 20(7):1215. PubMed ID: 9203475
    [No Abstract]   [Full Text] [Related]  

  • 7. Glibenclamide-induced cholestasis.
    Tholakanahalli VN; Potti A; Heyworth MF
    West J Med; 1998 Apr; 168(4):274-7. PubMed ID: 9584675
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-pharmacological conference].
    Lüllmann H; Schaefer HJ
    Dtsch Med Wochenschr; 1974 Apr; 99(17):916-7. PubMed ID: 4209433
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal toxic intrahepatic cholestasis secondary to glibenclamide.
    Krivoy N; Zaher A; Yaacov B; Alroy G
    Diabetes Care; 1996 Apr; 19(4):385-6. PubMed ID: 8729168
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-induced hypoglycemic coma in 102 diabetic patients.
    Ben-Ami H; Nagachandran P; Mendelson A; Edoute Y
    Arch Intern Med; 1999 Feb; 159(3):281-4. PubMed ID: 9989540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [2d generation hypoglycemic coma due to sulfanylureas].
    Cavatorta F; Queirolo C; Caraceni CE
    Arch Maragliano Patol Clin; 1973 Jan; 29(1):95-108. PubMed ID: 4209559
    [No Abstract]   [Full Text] [Related]  

  • 12. Glyburide-induced hemolysis in myelodysplastic syndrome.
    Noto H; Tsukamoto K; Kimura S
    Diabetes Care; 2000 Jan; 23(1):129. PubMed ID: 10857987
    [No Abstract]   [Full Text] [Related]  

  • 13. Glibenclamide--what dose?
    Rambiritch V; Pillai G; Maharaj B; Robertson LI
    S Afr Med J; 2007 Jul; 97(7):475. PubMed ID: 17805443
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypoglycemic coma due to antidiabetic sulfonamides. Apropos of 16 cases].
    Lauvaux JP; Thys O; Sternon J
    Acta Clin Belg; 1968; 23(3):153-62. PubMed ID: 5713675
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypoglycemic attacks caused by oral hypoglycemic drugs].
    Accettella U; Sacra A; Gentile M
    Policlinico Prat; 1970 Sep; 77(37):1173-8. PubMed ID: 5458801
    [No Abstract]   [Full Text] [Related]  

  • 16. The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide.
    Clemens KK; McArthur E; Dixon SN; Fleet JL; Hramiak I; Garg AX
    Can J Diabetes; 2015 Aug; 39(4):308-16. PubMed ID: 25840942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of cardiovascular events in diabetic patients taking sulphonylureas: need for assessment.
    Rohra DK; Maheshwary AR; Gauba SS
    J Pak Med Assoc; 2007 Mar; 57(3):163. PubMed ID: 17432030
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?
    Riddle MC
    J Clin Endocrinol Metab; 2003 Feb; 88(2):528-30. PubMed ID: 12574174
    [No Abstract]   [Full Text] [Related]  

  • 19. Glyburide-induced acute haemolysis in a G6PD-deficient patient with NIDDM.
    Meloni G; Meloni T
    Br J Haematol; 1996 Jan; 92(1):159-60. PubMed ID: 8562390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus.
    González-Ortiz M; Guerrero-Romero JF; Violante-Ortiz R; Wacher-Rodarte N; Martínez-Abundis E; Aguilar-Salinas C; Islas-Andrade S; Arechavaleta-Granell R; González-Canudas J; Rodríguez-Morán M; Zavala-Suárez E; Ramos-Zavala MG; Metha R; Revilla-Monsalve C; Beltrán-Jaramillo TJ
    J Diabetes Complications; 2009; 23(6):376-9. PubMed ID: 18849173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.